Sapient Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$597K Sell
6,509
-293
-4% -$25.6K 0.01% 250
2026
Q1
$580K Sell
6,802
-1,707
-20% -$152K 0.01% 252
2025
Q4
$677K Sell
8,509
-1,255
-13% -$98.4K 0.01% 235
2025
Q3
$785K Hold
9,764
0.01% 222
2025
Q2
$888K Buy
9,764
+162
+2% +$14.8K 0.02% 200
2025
Q1
$900K Sell
9,602
-388
-4% -$34.7K 0.02% 200
2024
Q4
$908K Buy
9,990
+157
+2% +$15K 0.02% 192
2024
Q3
$1.02M Hold
9,833
0.02% 190
2024
Q2
$954K Buy
9,833
+35
+0.4% +$3.23K 0.02% 176
2024
Q1
$882K Hold
9,798
0.02% 187
2023
Q4
$781K Buy
+9,798
New +$737K 0.02% 196

Other funds holding CL

Sapient Capital's CL Position: Q2 2026 in Review

Sapient Capital reduced its Colgate-Palmolive (CL) stake by 4.3% in Q2 2026, selling an estimated $25.6K and leaving 6,509 shares worth $597K. The position accounts for 0.01% of the portfolio, ranked #250.

Sapient Capital first reported a position in CL in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.02M in Q3 2024. 610 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Sapient Capital held 6,509 shares of Colgate-Palmolive worth $597K as of Q2 2026.
  • Sapient Capital sold 293 Colgate-Palmolive shares in Q2 2026, an estimated $25.6K.
  • Colgate-Palmolive made up 0.01% of Sapient Capital's portfolio in Q2 2026, its #250 holding.
  • Sapient Capital first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 11 quarters since.
  • Sapient Capital's Colgate-Palmolive position peaked at $1.02M in Q3 2024.
  • 610 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Sapient Capital's 13F filing for Q2 2026, filed 9 Jul 2026.